Does Pancreatic Stent Decrease the Risk of Pancreatitis After Pancreatic Sphincterotomy for Difficult Cannulation?
NCT ID: NCT04408482
Last Updated: 2024-02-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
268 participants
INTERVENTIONAL
2020-08-01
2024-09-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Prophylactic Pancreatic Duct Stenting in Acute Necrotizing Pancreatitis
NCT01767233
Post-ERCP Pancreatitis Prevention by Stent Insertion
NCT01673763
Early Pancreatic Duct Stent Removal in Preventing Post-endoscopic Pancreatitis
NCT01449084
Preoperative Stent Study
NCT00501176
Palliative Pancreatic Duct Stenting in Patients With Inoperable Pancreatic Cancer
NCT03069664
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Pancreatic sphincterotomy
Pancreatic sphincterotomy performed in difficult cannulation
Biliary cannulation
Cannulation of biliary duct by sphincterotome
Pancreatic sphincterotomy + pancreatic stent
Pancreatic sphincterotomy performed in difficult cannulation + pancreatic stent placement
Biliary cannulation
Cannulation of biliary duct by sphincterotome
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Biliary cannulation
Cannulation of biliary duct by sphincterotome
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
18 Years
100 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Helsinki University Central Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Andrea Tenca
Principal investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Helsinki Univeristy Hospital
Helsinki, , Finland
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Andrea Tenca, PhD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3509/2019
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.